New Guide Empowers Patients to Face Gout's Physical & Mental Toll
Patient Organizations Combine Resources for Comprehensive Guide
WASHINGTON, May 2, 2024 /PRNewswire/ -- The Alliance for Gout Awareness today released a resource guide to help patients navigate the physical and mental toll of gout, a form of arthritis that affects over 9 million Americans.
The paper features resources from the Alliance for Gout Awareness and its partners to address four key topics:
The physical pain of gout can be debilitating. It can disrupt work, complicate social activities and cause mobility issues. But the condition can also affect patients' mental health. The stigma associated with gout can keep patients from seeking treatment, leaving them to suffer in silence.
STATEMENT FROM JOSIE COOPER, EXECUTIVE DIRECTOR, ALLIANCE FOR GOUT AWARENESS
"This guide is an important resource for people living with gout. By seeking treatment for their physical and mental health, gout patients can reclaim their quality of life and manage both conditions successfully."
ABOUT THE ALLIANCE FOR GOUT AWARENESS
The Alliance for Gout Awareness works to reduce stigma and empower patients by improving public understanding of gout. https://www.goutalliance.org/
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company"). This action, captioned Hope v. agilon health, inc., et...
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market. The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...